European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Tenders

Pharmaceutical tenders in Czechia

Pharmaceutical tenders in Czechia: 262,444 listed on GranTender since 2024; 67 open now. The median awarded contract value is about €150,000 (5,818 contracts with a stated value). Buyers with the most tenders: Fakultní nemocnice Olomouc (27,374), Krajská zdravotní, a.s. (24,826) and Fakultní nemocnice Bulovka (24,823); suppliers with the most contract awards: ROCHE s.r.o. (8,353), ViaPharma s.r.o. (7,078) and Janssen-Cilag s.r.o. (6,255). Sources: Registr smluv, ISVZ (NIPEZ) and TED. In 2025 the median contract value was €4,600; 54% of contracts drew a single bid (5.5 bids on average). Data as of 17 November 2026; updated daily.

Tenders
262,444
Open tenders
67
Awards
268,573
Awarded value awarded
€7,183,537,145
Awarded value contract
€12,666,885,219
Awarded value framework ceiling
€2,550,460,527
Median contract value contract
≈ €4,600
Median contract value awarded
≈ €150,000
Median contract value framework ceiling
≈ €180,000
Average bids per contract
5.1
Tenders in 2025
91,650 +23% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

TenderBuyerEstimated valueStatusPublished
LP s obsahem glekapeviru a pibrentasviru 2026 - sdružený nákupFakultní nemocnice OlomoucCZK 64,934,100 (≈ €2,672,625)Open16 November 2026
Léčivé přípravky s obsahem amivantamabuFakultní nemocnice Hradec KrálovéCZK 2,706,000 (≈ €111,376)Open16 November 2026
Léčivé přípravky pro zažívací trakt a metabolismusInstitut klinické a experimentální medicínyCZK 58,584,000 (≈ €2,411,261)Open13 November 2026
Dodávky léčivého přípravku s účinnou látkou CangrelorumFakultní nemocnice OstravaCZK 13,596,132 (≈ €559,604)Open13 November 2026
Cytostatikum, inhibitor tyrozinkináz s účinnou látkou CrizotinibumFakultní nemocnice OstravaCZK 7,962,967 (≈ €327,748)Open13 November 2026
Perorální antivirotikum s kombinací účinných látek Darunavirum a CobicistatumFakultní nemocnice OstravaCZK 3,949,472 (≈ €162,556)Open13 November 2026
Nákup léčiv – nemocnice s poliklinikou Praha 2027-2028Zdravotnická zařízení Ministerstva spravedlnostiCZK 9,094,635 (≈ €374,326)Open13 November 2026
Léčivý přípravek s účinnou látkou MelphalanumFakultní nemocnice OstravaCZK 1,850,003 (≈ €76,144)Open13 November 2026
Cytostatikum s účinnou látkou FluorouracilumFakultní nemocnice OstravaCZK 4,135,588 (≈ €170,217)Open13 November 2026
Parenterální cytostatikum s účinnou látkou IfosfamidumFakultní nemocnice OstravaCZK 6,288,884 (≈ €258,844)Open13 November 2026
Léčivé přípravky s obsahem fampridinuFakultní nemocnice Hradec KrálovéCZK 4,710,000 (≈ €193,859)Open12 November 2026
Imunosupresiva - inhibitor kalcineurinu II. - cyklosporinInstitut klinické a experimentální medicínyCZK 13,999,000 (≈ €576,185)Open11 November 2026
Heparinum natricum II.Institut klinické a experimentální medicínyCZK 41,786,000 (≈ €1,719,872)Open11 November 2026
LP s obsahem siponimodu - sdružený nákup 2026Fakultní nemocnice OlomoucCZK 106,969,190 (≈ €4,402,749)Open11 November 2026
Léčivý přípravek ATC skupiny S01LA06 s účinnou látkou BROLUCIZUMABNemocnice Pardubického kraje, a.s.CZK 6,201,600 (≈ €255,252)Open10 November 2026
Léčivý přípravek ATC skupiny D11AH10 s účinnou látkou LEBRIKIZUMABNemocnice Pardubického kraje, a.s.CZK 24,039,000 (≈ €989,422)Open10 November 2026
Léčivý přípravek ATC skupiny L04AA40 s účinnou látkou KLADRIBINNemocnice Pardubického kraje, a.s.CZK 44,014,440 (≈ €1,811,592)Open10 November 2026
Kardiaka 16 - AmiodaronInstitut klinické a experimentální medicínyCZK 573,000 (≈ €23,584)Open10 November 2026
LP s obsahem ponatinibu 2026 - sdružený nákupFakultní nemocnice OlomoucCZK 27,577,746 (≈ €1,135,074)Open10 November 2026
Dodávka vitaminových přípravků 2027-2028Česká průmyslová zdravotní pojišťovnaCZK 8,500,000 (≈ €349,852)Open6 November 2026

Latest tenders

TenderBuyerEstimated valueStatusPublished
LP s obsahem glekapeviru a pibrentasviru 2026 - sdružený nákupFakultní nemocnice OlomoucCZK 64,934,100 (≈ €2,672,625)Open16 November 2026
Léčivé přípravky s obsahem amivantamabuFakultní nemocnice Hradec KrálovéCZK 2,706,000 (≈ €111,376)Open16 November 2026
Léčivé přípravky pro zažívací trakt a metabolismusInstitut klinické a experimentální medicínyCZK 58,584,000 (≈ €2,411,261)Open13 November 2026
Dodávky léčivého přípravku s účinnou látkou CangrelorumFakultní nemocnice OstravaCZK 13,596,132 (≈ €559,604)Open13 November 2026
Cytostatikum, inhibitor tyrozinkináz s účinnou látkou CrizotinibumFakultní nemocnice OstravaCZK 7,962,967 (≈ €327,748)Open13 November 2026
Perorální antivirotikum s kombinací účinných látek Darunavirum a CobicistatumFakultní nemocnice OstravaCZK 3,949,472 (≈ €162,556)Open13 November 2026
Nákup léčiv – nemocnice s poliklinikou Praha 2027-2028Zdravotnická zařízení Ministerstva spravedlnostiCZK 9,094,635 (≈ €374,326)Open13 November 2026
Léčivý přípravek s účinnou látkou MelphalanumFakultní nemocnice OstravaCZK 1,850,003 (≈ €76,144)Open13 November 2026
Cytostatikum s účinnou látkou FluorouracilumFakultní nemocnice OstravaCZK 4,135,588 (≈ €170,217)Open13 November 2026
Parenterální cytostatikum s účinnou látkou IfosfamidumFakultní nemocnice OstravaCZK 6,288,884 (≈ €258,844)Open13 November 2026
Léčivé přípravky s obsahem fampridinuFakultní nemocnice Hradec KrálovéCZK 4,710,000 (≈ €193,859)Open12 November 2026
JANSSEN-CILAG - 127882 - Nákup léčivých přípravků/zdravotnického materiáluVšeobecná fakultní nemocnice v Praze—Awarded12 November 2026
Rámcová kupní smlouva - Dodávka léčivých přípravků s obsahem Jomeprolu, injekční roztokNemocnice Na Františku—Awarded12 November 2026
Dodávky léčivého přípravku s účinnou látkou etelkalcetid hydrochlorid v dílčích dodávkách po dobu 2 let.Nemocnice Třebíč, příspěvková organizace—Awarded12 November 2026
Smlouva na postupné dodávky léků - LL nerandomilast (JASCAYD)Fakultní Thomayerova nemocnice—Awarded11 November 2026
Imunosupresiva - inhibitor kalcineurinu II. - cyklosporinInstitut klinické a experimentální medicínyCZK 13,999,000 (≈ €576,185)Open11 November 2026
Heparinum natricum II.Institut klinické a experimentální medicínyCZK 41,786,000 (≈ €1,719,872)Open11 November 2026
Janssen Cilag s.r.o. - 30909 - Nákup léčivých přípravků/zdravotnického materiáluVšeobecná fakultní nemocnice v Praze—Awarded11 November 2026
Roche s.r.o - 30908 - Nákup léčivých přípravků/zdravotnického materiáluVšeobecná fakultní nemocnice v Praze—Awarded11 November 2026
Rámcová kupní smlouva - léčiva - PC desktopy pro FNUSAFakultní nemocnice u sv. Anny v Brně—Awarded11 November 2026

Competition and prices

In 2025, half of the contracts were worth between €2,900 and €10,000, with a median of €4,600 (85,945 contracts with a stated contract value). Contracts drew 5.5 bids on average (median 1) and 54% drew a single bid — based on 4,950 contracts with a known number of bids. Compared with 2024, in 2025 the share of single-bid contracts fell from 56% to 54%. The usual procedures: open procedure (65%), other procedures (30%), restricted procedure (2%) — of 6,409 tenders with a stated procedure.

The most contracts went to ROCHE s.r.o. (8,353), ViaPharma s.r.o. (7,078) and Janssen-Cilag s.r.o. (6,255) — together 8% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
202475,672€4,600 (contract value)€2,700 – €10,0004.056% (2,887)
202594,700€4,600 (contract value)€2,900 – €10,0005.554% (4,950)
2026 (so far)96,469€4,900 (contract value)€2,900 – €12,0005.654% (3,466)
All years267,231€4,600 (contract value)€2,900 – €11,0005.155% (11,514)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

In the last 12 months, 58 companies won their first contract in our records here — 0% of the 46,154 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33600000 Pharmaceutical products

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Medicines and pharmaceuticals in neighbouring countries

Today, 1,801 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

ExpectedBuyerWhatWhy we expect itConfidence
now – Dec 2026
every year
Zdravotnická záchranná služba Olomouckého kraje, příspěvková organizaceMedicines and pharmaceuticals
RKS o průběžné dodávce léčiv pro ZZS OK na rok 2026.
The buyer has published pharmaceutical tenders every year in November since 2024.
Earlier tenders: 11/2025, 11/2024
medium
now – Feb 2027
contract ends
Oblastní nemocnice Příbram, a.s.Medicines and pharmaceuticals
Léková molekula - Sufentanyl - společné zadávání
Typical value: ≈ €63,000
The current contract with PHARMOS, a.s. ends on 18 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 04/2025
medium
now – Feb 2027
contract ends
Centrum kardiovaskulrní a transplantační chirurgie BrnoMedicines and pharmaceuticals
Dodavatel léčivých přípravků a služeb nemocniční lékárny 2026
Typical value: ≈ €3.5m
The current contract with Fakultní nemocnice u sv. Anny v Brně ends on 25 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 12/2025
high
now – Mar 2027
contract ends
Nemocnice Jablonec nad Nisou, p.o.Medicines and pharmaceuticals
Léčivý přípravek s účinnou látkou PANTOPRAZOL
Typical value: ≈ €28,000
The current contract with Alliance Healthcare s.r.o. ends on 1 April 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 01/2025
medium
now – Apr 2027
contract ends
Zdravotnické zařízení Ministerstva vnitraMedicines and pharmaceuticals
Průběžné nákupy vakcín pro Zdravotnické zařízení Ministerstva vnitra
Typical value: ≈ €2.1m
The current contract with Avenier a.s. ends on 5 May 2027; no new tender has been published yet.
Earlier tenders: 02/2024
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Medicines and pharmaceuticals by city

Medicines and pharmaceuticals in other countries

Medicines and pharmaceuticals across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which pharmaceutical tenders in Czechia are open now?
67 of the 262,444 pharmaceutical tenders in Czechia listed on GranTender are open for bids. For example: LP s obsahem glekapeviru a pibrentasviru 2026 - sdružený nákup; Léčivé přípravky s obsahem amivantamabu; Léčivé přípravky pro zažívací trakt a metabolismus.
Where can I find pharmaceutical tenders in Czechia?
GranTender lists them in one place, from Registr smluv, ISVZ (NIPEZ) and TED, with their buyers, winners and contract values; 67 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most pharmaceutical tenders in Czechia?
By number of contracts won: ROCHE s.r.o. (8,353), ViaPharma s.r.o. (7,078), Janssen-Cilag s.r.o. (6,255).
Which buyers publish the most pharmaceutical tenders in Czechia?
By number of tenders: Fakultní nemocnice Olomouc (27,374), Krajská zdravotní, a.s. (24,826), Fakultní nemocnice Bulovka (24,823).
Which CPV codes belong to “Medicines and pharmaceuticals”?
33600000 Pharmaceutical products; plus tenders without a usable CPV code whose title names the topic.
How many bids do pharmaceutical tenders in Czechia receive on average?
In 2025, contracts drew 5.5 bids on average (median 1) and 54% drew a single bid — based on 4,950 contracts with a known number of bids.
How much are contracts for pharmaceutical tenders in Czechia worth?
In 2025, half of the contracts were worth between €2,900 and €10,000, with a median of €4,600 (85,945 contracts with a stated contract value). Compared with 2024, in 2025 the share of single-bid contracts fell from 56% to 54%.
Which procedures are used for pharmaceutical tenders in Czechia?
The usual procedures: open procedure (65%), other procedures (30%), restricted procedure (2%) — of 6,409 tenders with a stated procedure.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.